Efficacy and safety of third-generation CD19-CAR T cells incorporating CD28 and TLR2 intracellular domains for B-cell malignancies with central nervous system involvement: results of a pivotal trial.
Saved in:
| Title: | Efficacy and safety of third-generation CD19-CAR T cells incorporating CD28 and TLR2 intracellular domains for B-cell malignancies with central nervous system involvement: results of a pivotal trial. |
|---|---|
| Authors: | He, Bailin1,2 (AUTHOR), Lin, Ren1,2 (AUTHOR), Xu, Na1,2 (AUTHOR), Qin, Le3 (AUTHOR), Wang, Zhixiang1,2 (AUTHOR), Wang, Qiang1,2 (AUTHOR), Li, Xiaofang1,2 (AUTHOR), Wei, Xiaolei1,2 (AUTHOR), Wei, Yongqiang1,2 (AUTHOR), Tang, Zhaoyang4 (AUTHOR), Fan, Zhiping1,2 (AUTHOR), Huang, Fen1,2 (AUTHOR), Liu, Xiaoli1,2 (AUTHOR), Sun, Jing1,2 (AUTHOR), Xuan, Li1,2 (AUTHOR), Li, Peng3 (AUTHOR) li_peng@gibh.ac.cn, Zhou, Hongsheng1,2 (AUTHOR) hanson_tcm@126.com, Liu, Qifa1,2 (AUTHOR) liuqifa628@163.com |
| Source: | Journal of Translational Medicine. 5/27/2025, Vol. 23 Issue 1, p1-12. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14795876 |
|---|---|
| DOI: | 10.1186/s12967-025-06608-x |
